Vascular dementia diagnostic study of choice

Jump to navigation Jump to search

Vascular dementia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electroencephalogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vascular dementia diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vascular dementia diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vascular dementia diagnostic study of choice

CDC on Vascular dementia diagnostic study of choice

Vascular dementia diagnostic study of choice in the news

Blogs on Vascular dementia diagnostic study of choice

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Vascular dementia diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]

Overview

Diagnostic Study of Choice

Study of choice

  • There is no single diagnostic study of choice for the diagnosis of Vascular dementia , but Vascular dementia can be diagnosed based on MRI and CT scan.

Name of Diagnostic Criteria

  • There is no single diagnostic study of choice for Vascular dementia, though Vascular dementia may be diagnosed based on DSM-5.[1]
  • The diagnosis of Vascular dementia is based on the DSM-5 criteria, which include:[1]
    • Parenchymal injury attributing to cerebrovascular disease.
    • One or more documented cerebrovascular events.
    • Both clinical and genetic causes.

References

  1. 1.0 1.1 Hendrickson WA, Ward KB, Bland RD, Clarke TL, Harden LB (October 1975). "Atomic models for the polypeptide backbones of myohemerythrin and hemerythrin". Biochem. Biophys. Res. Commun. 66 (4): 1349–56. PMID 5.

Template:WH Template:WS